Gliclazide 80 Mg + Metformin Hydrochloride 500 Mg

This medication is primarily prescribed for the management of type 2 diabetes mellitus. It helps control blood sugar levels by addressing multiple aspects of glucose metabolism. Gliclazide Ip 80 Mg + Metformin 500 Mg combination medication is also used to reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, nephropathy, and retinopathy. By maintaining stable blood sugar levels and improving insulin sensitivity, this medication helps mitigate the adverse effects of hyperglycemia on various organs and tissues in the body.

The dosage of Gliclazide Ip 80 Mg + Metformin 500 Mg may vary depending on the patient's blood sugar levels It is typically taken orally, usually once or twice daily with meals to reduce the risk of gastrointestinal side effects.

Keep this medicine out of the sight and reach of children. Do not store above 25C. Store in the original package.

Hypoglycemia (low blood sugar), Gastrointestinal symptoms such as nausea, diarrhea, or abdominal discomfort, Headache, Dizziness, Weight gain (less common with metformin.

If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. You must not take this medicine while you are breast-feeding.

This medicine be used with caution in elderly patients, as they may be more susceptible to hypoglycemia and other adverse effects. Patients should be advised to avoid excessive alcohol consumption while taking Gliclazide, as alcohol may potentiate the risk of hypoglycemia. Tablets are not recommended for use during pregnancy. If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. You must not take this medicine while you are breast-feeding Drinking alcohol is not recommended as it can alter the control of your diabetes in an unpredictable manner.

Product Information: RIOMET ER(TM) oral extended-release suspension, metformin HCl oral extended-release suspension. Sun Pharmaceutical Industries Inc (per FDA), Cranbury, NJ, 2019. Product Information: GLUMETZA(R) oral extended-release tablets, metformin HCl oral extended-release tablets. Valeant Pharmaceuticals of North America (per FDA), Bridgewater, NJ, 2017. https://www.drugs.com/uk/pdf/leaflet/1084506.pdf (Zircon product leaflet) Bressler R & Johnson DG: Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus. Arch Intern Med 1997; 157:836-848.

Gliclazide stimulates insulin secretion from pancreatic beta cells, which helps to lower blood sugar levels. Metformin reduces hepatic glucose production, enhances peripheral glucose uptake and utilization, and decreases intestinal glucose absorption.

Anti Diabetic.